Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

A rare autoimmune disease caused the woman's scalp blisters and hair loss, successfully treated with medication.

Certain patient characteristics can help predict hair regrowth success with ritlecitinib in alopecia areata.

Microneedling radiofrequency improves skin texture and tone by stimulating collagen and elastin.

Hair growth-related cells need the enzyme SCD1 to help maintain the area that supports hair growth.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Stroma structural changes cause large pores and skin laxity, regardless of age or ethnicity.

Alhydran and DermaCress moisturizers are more effective and cost-efficient for scar hydration than silicone gel.

Microporous scaffolds speed up skin healing and regeneration.

PCR genotyping in cre-loxP mice can be inaccurate due to unintended gene deletions in non-target tissues.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

Mouse epidermal neural crest stem cells can become various cell types and are easily obtained from hair follicles.

Mutations in the SNRPE gene cause hereditary hair loss.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Baicalin may help treat severe drug-induced skin reactions.

The device is useful for anesthesia, healing treatments, and preventing hair loss.

Double trichophytic closure effectively treats thin scalp scars and reduces patient costs.

Cats infested with Lynxacarus radovskyi can lose hair without inflammation, treatable with selamectin.

BSSP may help skin tumors grow and could be a marker or target for skin cancer treatment.

New therapy helps treat hair loss.

3D virtual planning can help in precise skull reconstruction for advanced skin cancer, but patient-specific factors must be considered.

Generative AI tools can accurately score alopecia areata, reducing subjectivity in evaluations.

Defects in certain proteins cause major heart abnormalities during early development.

Diagnosing and treating CCCA requires understanding multiple causes and using various diagnostic tools.